B cell response to surface IgM cross-linking identifies different prognostic groups of B-chronic lymphocytic leukemia patients

Journal of Immunology

Volumn 174, Issue 6, 2005, Pages 3749-3756

  Nédellec, Steven ^a   Renaudineau, Yves ^a   Bordron, Anne ^a   Berthou, Christian ^a   Porakishvili, Nina ^b   Lydyard, Peter M ^b   Pers, Jacques Olivier ^a   Youinou, Pierre ^a,c  

^a FACULTÉ DE MÉDECINE ET DES SCIENCES DE LA SANTÉ   (France)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c BREST UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CD38 ANTIGEN; CD79B ANTIGEN; IMMUNOGLOBULIN M; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN KINASE ZAP 70;

ADULT; AGED; APOPTOSIS; ARTICLE; B CELL LEUKEMIA; B LYMPHOCYTE ACTIVATION; CALCIUM MOBILIZATION; CANCER STAGING; CELL ASSAY; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; FEMALE; FLOW CYTOMETRY; GENE MUTATION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOGLOBULIN VARIABLE REGION; LIPID RAFT; LYMPHOCYTE PROLIFERATION; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

EID: 14844366139     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.6.3749     Document Type: Article

References (53)

1. Keating, M. J. 1999. Chronic lymphocytic leukemia. Semin. Oncol. 26(Suppl 14):107.
2. Caligaris-Cappio, F., and T. J. Hamblin. 1999. B-cell chronic lymphocytic leukemia: a bird of a different feather. J. Clin. Oncol. 17:399.
3. Chiorazzi, N., and M. Ferrarini. 2001. B cell chronic lymphocytic leukemia: lessons learned from studies of the B cell antigen receptor. Annu. Rev. Immunol. 21:841.
4. Kay, N. E., and D. F. Jelinek. 2002. B-CLL: is the enigma of disease heterogeneity about to be revealed? Blood 100:1110.
5. Bernal, A., R. D. Pastore, Z. Asgary, S. A. Keller, E. Cesarman, H. C. Liou, and E. J. Schattner. 2001. Survival of leukemic B cells promoted by engagement of the antigen receptor. Blood 98:3050.
6. 2+ mobilization and cell proliferation. Eur. J. Immunol. 18:1811.
7. McConkey, D. J., M. Aguilar-Santelises, P. Hartzell, I. Eriksson, H. Mellstedt, S. Orrenius, and M. Jondal. 1991. Induction of DNA fragmentation in chronic B-lymphocytic leukemia cells. J. Immunol. 146:1072.
8. Zupo, S., L. Isnardi, M. Megna, R. Massara, F. Malavasi, M. Dono, E. Cosulich, and M. Ferrarini. 1996. CD38 expression distinguishes 2 groups of B-chronic lymphocytic leukemias with different responses to anti-IgM antibodies and propensity to apoptosis. Blood 88:1365.
9. Zupo, S., R. Massara, M. Dono, E. Rossi, F. Malavasi, M. E. Cosulich, and M. Ferrarini. 2000. Apoptosis of plasma cell differentiation of CD38-positive B-chronic lymphocytic leukemia cells induced by cross-linking of surface IgM or IgD. Blood 95:1199.
10. Damle, R. N., T. Wasil, F. Fais, F. Ghiotto, A. Valetto, S. L. Allen, A. Buchbinder, D. Budman, K. Dittmar, J. Kolitz, et al. 1999. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 94:1840.
11. Ghia, P., G. Guida, S. Stella, D. Gottardi, M. Geuna, G. Strola, C. Scielzo, and F. Caligaris-Cappio. 2003. The pattern of CD38 expression defines a distinct subset of chronic lymphocytic patients at risk of disease progression. Blood 101:1262.
12. Pittner, B. T., D. F. Jelinek, and N. E. Kay. 2004. CLL B cells with a bimodal CD38 expression pattern: persistence of bimodal populations despite effective therapy for B-CLL. Leukemia 18:180.
13. H gene mutational status and CD38 expression chronic lymphocytic leukemia. Blood 101:1087.
14. H genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 94:1848.
15. Oppezzo, P., C. Magnac, S. Bianchi, F. Vuillier, A. Tiscornia, G. Dumas, B. Payelle-Brogard, F. Ajchenbaum-Cymbalista, G. Dighiero, and O. Pritsch. 2002. Do CLL B cells correspond to naïve or memory B-lymphocytes? Evidence for an active Ig switch unrelated to phenotype expression and Ig mutational patterns in B-CLL cells. Leukemia 16:2438.
16. Pers, J. O., C. Berthou, N. Porakishvili, M. Burdjanadze, G. Le Calvez, J. F. Abgrall, P. M. Lydyard, P. Youinou, and C. Jamin. 2002. CD5-induced apoptosis of B cells in some patients with chronic lymphocytic leukemia. Leukemia 16:44.
17. Renaudineau, Y., S. Nédellec, C. Berthou, P. M. Lydyard, P. Youinou, and J. O. Pers. 2005. Role of B cell antigen receptor-associated molecules and lipid rafts in CD5-induced apoptosis of B CLL cells. Leukemia. 19:223.
18. Cioca, D. P., and K. Kitano. 2002. Apoptosis induction by hypercross-linking of the surface antigen CD5 with anti-CD5 monoclonal antibodies in B cell chronic lymphocytic leukemia. Leukemia 16:335.
19. Zomas, A. P., E. Matutes, R. Morilla, K. Owusu-Ankomah, B. K. Seon, and D. Catovsky. 1996. Expression of immunoglobulin-associated proteins in B cell disorders with the monoclonal antibody SN8 (CD79B). Leukemia 10:1966.
20. Thompson, A. A., J. A. Talley, H. N. Do, H. L. Kagan, L. Kunkel, J. Berenson, M. D. Cooper, A. Saxon, and R. Wall. 1997. Aberrations of the B-cell receptor B29 gene in chronic lymphocytic leukemia. Blood 90:1387.
21. Alfarano, A., S. Indraccalo, P. Circosta, S. Minuzzo, A. Vallario, R. Zamarchi, A. Fregonese, F. Calderazzo, A. Faldella, M. Aragno, et al. 1999. Alternatively spliced form of CD79B may account for altered B-cell receptor expression in B-chronic lymphocytic leukemia. Blood 93:2327.
22. Alfarano, A., P. Circosta, A. Vallario, C. Camaschella, S. Indraccolo, A. Amadori, and F. Caligaris-Cappio. 1999. Alternative splicing of CD79A (Igα) and CD79B (Igβ) transcripts in B-CLL cells. Curr. Top. Microbiol. Immunol. 246:241.
23. Pierce, S. K. 2002. Lipid rafts and B-cell activation. Nat. Rev. Immunol. 2:96.
24. Klein, U., Y. Tu, G. A. Stolovitzky, M. Mattioli, G. Cattoretti, H. Husson, A. Freedman, G. Inghirami, L. Cro, L. Baldini, et al. 2001. Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J. Exp. Med. 194:1625.
25. Rosenwald, A., A. A. Alizadeh, G. Widhopf, R. Simon, R. E. Davis, X. Yu, L. Yang, O. K. Pickeral, L. Z. Rassenti, J. Powell, et al. 2001. Relation of gene expression phenotype to immunoglobulin genotype in B chronic lymphocytic leukemia. J. Exp. Med. 194:1639.
26. Chen, L., G. Widhopf, L. Huynh, L. Rassenti, K. R. Rai, A. Weiss, and T. Kipps. 2002. Expression of Zap-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia. Blood 100:4609.
27. Dürig, J., H. Nückel, M. Cremer, A. Fuhrer, K. Halfmeyer, J. Fandrey, T. Moroy, L. Klein-Hitpass, and U. Duhrsen. 2003. Zap-70 expression is a prognostic factor in chronic lymphocytic leukemia. Leukemia 17:2426.
28. Wiestner, A., A. Rosenwald, T. S. Barry, G. Wright, R. E. Davis, S. Henrickson, H. Zhao, R. E. Ibbotson, J. A. Orchard, Z. Davis, et al. 2003. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood 101:4944.
29. Yao, R., and G. M. Cooper. 1995. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science 267:2003.
30. Datta, S. R., A. Brunet, and M. E. Greenberg. 1999. Cellular survival: a play in 3 Akts. Genes Dev. 13:2905.
31. Barragán, M., B. Bellosillo, C. Campàs, D. Colomer, G. Pons, and J. Gil. 2002. Involvement of protein kinase C and phosphatidylinositol 3-kinase pathways in the survival of B-cell chronic lymphocytic leukemia cells. Blood 9:2969.
32. Ringshausen, I., F. Schneller, C. Bogner, S. Hipp, J. Duyster, C. Peschel, and T. Decker. 2002. Constitutively activated phosphatidyinositol- 3′ kinase (PI-3K) is involved in the defect of apoptosis in B-CLL: association with protein kinase Cδ. Blood 100:3741.
33. 3. J. Biol. Chem. 69:32358.
34. Xia, Z., M. Keckens, J. Raingeaud, R. J. Davis, and M. E. Greenberg. 1995. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326.
35. Healy, J. I., and C. C. Goodnow. 1998. Positive versus negative signaling by lymphocyte antigen receptors. Annu. Rev. Immunol. 16:643.
36. Michel, F., H. Merle-Béral, E. Legac, A. Michel, P. Debré, and G. Bismuth. 1993. Defective calcium response in B-chronic lymphocytic leukemia cells: alteration of early protein tyrosine phosphorylation and of the mechanism responsible for cell calcium influx. J. Immunol. 150:3624.
37. Lankester, A. C., G. M. van Schijndel, C. E. van der Schoot, M. H. van Oers. C. J. van Noesel, and R. A. van Lier. Antigen receptor nonresponsiveness in chronic lymphocytic leukemia B cells. Blood 86:1090.
38. Deaglio, S., A. Capobianco, L. Bergui, J. Durig, F. Morabito, U. Duhrsen, and F. Malavasi. 2003. CD38 is a signaling molecule in B-cell chronic lymphocytic leukemia cells. Blood 102:2146.
39. Matutes, E., and D. Catovsky. 1994. The value of scoring systems for the diagnosis of biphenotypic leukemias and mature B-cell disorders. Leuk. Lymphoma 13:11.
40. Binet, J. L., A. Auquier, G. Dighiero, C. Chastang, H. Piguet, J. Goasguen, G. Vaugier, G. Potron, P. Colona, F. Oberling, et al. 1981. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 48:198.
41. Pers, J. O., C. Jamin, R. Le Corre, P. M. Lydyard, and P. Youinou. 1998. Ligation on resting B cells results in apoptosis. Eur. J. Immunol. 28:4170.
42. Bordron, A., M. Dueymes, Y. Levy, C. Jamin, J. P. Leroy, J. C. Piette, Y. Shoenfeld, and P. Youinou. 1998. The binding of human antiendothelial all antibodies induces endothelial cell apoptosis. J. Clin. Invest. 101:2029.
43. Cragg, M. S., H. T. Chan, M. D. Fox, A. Tutt, A. Smith, D. G. Oscier, T. J. Hambljn, and M. J. Glennie. 2002. The alternative transcript of CD79B is overexpressed in B-CLL and inhibits signaling. Blood 100:3068.
44. -ΔΔCt method. Methods 25:402.
45. Fais, F., F. Ghiotto, S. Hashimoto, B. Sellars, A. Valetto, S. L. Allen, P. Schulman, V. P. Vinciguerra, K. Rai, L. Z. Rassenti, et al. 1998. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J. Clin. Invest. 102:1515.
46. Toullec, D., P. Pianetti, H. Coste, P. Bellevergue, T. Grand-Perret, M. Ajakane, V. Baudet, P. Baissin, E. Boursier, F. Loriolle, et al. 1991. The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J. Biol. Chem. 266:15771.
47. Gold, M. R., M. P. Scheid, L. Santos, M. Dang-Lawson, R. A. Roth, L. Matsuuchi, V. Duronio, and D. L. Krebs. 1999. The B cell antigen receptor activates the Akt (protein kinase B)/glycogen synthase kinase-3 signaling pathway via phosphatidylinositol 3-kinase. J. Immunol. 163:1894.
48. 2+ flux. Curr. Biol. 10:393.
49. Douglas, R. S., R. J. Capocasale, R. J. Lamb, P. C. Nowell, and J. S. Moore. 1997. Chronic lymphocytic leukemia B cells are resistant to the apoptotic effects of transforming growth factor-β. Blood 89:941.
50. Panayiotidis, P., K. Ganeshaguru, L. Foroni, and A. V. Hoffbrand. 1995. Expression and function of the Fas antigen in B chronic lymphocytic leukemia and hairy cell leukemia. Leukemia 9:1227.
51. Granziero, L., P. Ghia, P. Circosta, D. Gottardi, G. Strola, M. Geuna, L. Montagna, P. Piccoli, M. Chilosi, and F. Caligaris-Cappio. 2001. Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-chronic lymphocytic leukemia. Blood 97:2777.
52. Stevenson, F. K., and F. Caligaris-Cappio. 2004. Chronic lymphocytic leukemia: revelations from the B-cell receptor. Blood 103:4389.
53. Chen, L., J. Apgar, L. Huynh, F. Dicker, T. Giago-McGahan, L. Rassenti, A. Weiss, and T.J. Kipps. ZAP-70 directly enhances IgM signaling in chronic lymphocytic leukemia. Blood. In press.